
For OTC, DTC diagnostic, and consumer health brands, affiliate marketing is a real acquisition channel, but only if partner claims, disclosures, and content stay inside FTC and FDA requirements. We build the program so it scales without becoming a liability.
Affiliate content routinely makes claims your regulatory team never approved
Health and wellness affiliates – review sites, comparison content, influencers – are incentivized to write whatever converts, and "converts" in this category often means efficacy or safety claims that exceed what your labeling and regulatory approval actually support. Once that content is live on someone else's site, it's associated with your brand and creates real exposure, and most programs have no process for reviewing affiliate content before or after it publishes.
FTC disclosure requirements get ignored by partners who don't think it applies to them
FTC endorsement guidelines require clear disclosure of paid or affiliate relationships, and health content creators frequently treat this as optional or bury it in a way that doesn't meet the actual standard. A brand can face enforcement exposure for a partner's non-compliant disclosure even when the brand didn't write the content, and most affiliate programs have no monitoring in place to catch it before it becomes a problem.
Partner vetting stops at traffic volume instead of credibility and compliance fit
Affiliate networks make it easy to approve partners based on traffic and conversion potential alone, without evaluating whether a partner's existing content already makes questionable health claims about other products, or whether their audience and format are appropriate for the specific product category. A high-traffic partner with a history of overstated claims elsewhere is a liability wearing a growth opportunity's clothes.
Commission structures incentivize exactly the behavior that creates compliance risk
Standard CPA-based affiliate commissions reward whatever content converts best, and in health categories that's frequently the most aggressive, least accurate claim. Without a commission and content approval structure that accounts for this, the program's own economics push partners toward the content that creates the most regulatory exposure.
We start by defining what's actually eligible for affiliate promotion within your regulatory category – OTC products, DTC diagnostics, wellness and consumer health lines – and building a claims guide that translates your approved labeling and regulatory boundaries into language partners can actually use, since most compliance documents aren't written for a content creator to work from directly.
From there we vet partners on credibility and compliance history, not just traffic volume. That means reviewing a prospective affiliate's existing content for prior claims patterns before approval, not after a problem surfaces, and matching partner type – comparison sites, health content creators, referral partnerships with adjacent providers – to what's actually appropriate for your specific product category and audience.
We build a content review process that scales without becoming a bottleneck. High-risk content categories – anything touching efficacy, safety, or comparison claims – route through a review step before or shortly after publication, while lower-risk content like general brand mentions or educational context can move faster. Every partner agreement includes explicit disclosure requirements aligned to current FTC endorsement guidelines, and we monitor live partner content on a recurring cadence to catch drift before it compounds.
Commission structure gets designed to reward the right behavior. Rather than a flat CPA that pushes toward whatever converts regardless of accuracy, we structure incentives and partner tiering around compliant, high-quality content performance, so the program's own economics support the compliance program instead of working against it.
An affiliate program in health and pharma isn't a traffic acquisition tactic bolted onto compliance review – it's a compliance program that happens to acquire customers. Programs built the other way around eventually generate a claim nobody signed off on.
We run this as a 90-day sprint built around the two failures that create most of the risk in health-category affiliate programs: content claims that exceed what regulatory approval supports, and disclosure practices that don't meet FTC standards. The first 30 days are diagnostic – scoping which products and claims are eligible for affiliate promotion, auditing any existing affiliate content for claims and disclosure issues, and building the claims guide partners will actually use. Days 30 to 60 stand up partner vetting, the content review workflow, and compliant commission structure, working directly with your regulatory and legal reviewers so the process reflects real approval requirements rather than a generic marketing compliance checklist. The final 30 days launch or relaunch the program with partners onboarded under the new structure and monitoring live.
What separates this from a standard affiliate marketing agency is that most affiliate agencies optimize purely for partner volume and conversion rate, treating compliance as the client's problem to sort out separately. We build the claims guide, vetting criteria, and review workflow as core program infrastructure from day one, because for most biotech and pharma consumer brands the real risk isn't that affiliate marketing doesn't work – it's that it works well enough to scale a compliance problem before anyone catches it.
The first 30 days are audit and scoping. We work with your regulatory and legal team to define which products and claims are eligible for affiliate promotion, audit any existing affiliate activity for compliance gaps, and build the claims guide and vetting criteria. Days 30 through 60 stand up the partner program – vetting current or prospective affiliates, building the content review workflow, and structuring compliant commissions. By day 90 the program is live or relaunched with monitoring in place.
On our side, the team is an affiliate program lead who owns partner strategy and content review, working directly with your regulatory and legal reviewers rather than treating compliance as a separate downstream check. From your side, we need access to your current affiliate platform or network if one exists, regulatory and legal review capacity to approve the claims guide, and a point of contact who can turn around content review decisions without creating a bottleneck for partners.
Cadence is weekly during the first 90 days, covering partner vetting progress, claims guide development, and workflow implementation, with async review turnaround for time-sensitive partner content questions once the program is live. After the initial sprint, most engagements move to a monthly cadence covering partner performance and ongoing content monitoring. Typical engagement length is 3 to 6 months for the initial buildout, with many programs continuing on an ongoing management retainer given the recurring monitoring the category requires.
What to expect at each phase: month one often surfaces existing compliance gaps in any current affiliate activity, which is uncomfortable but far better addressed proactively. Month two shows the vetted partner roster and review workflow taking shape. Month three onward is where the program starts producing measurable acquisition volume within a structure your legal and regulatory team can actually stand behind.
If your biotech & pharma company needs affiliate marketing leadership, we should talk.

Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Most engagements with us run $6K-14K monthly for program management, plus affiliate commissions paid on performance, which vary by product category and margin. That's typically less than the cost of an in-house affiliate manager plus separate legal review time, since compliance is built into the program structure rather than handled as a separate function. Programs spanning multiple product lines or complex claims environments sit toward the higher end.
Program scoping and the claims guide typically take the first 2-3 weeks, since they require regulatory and legal input. Partner vetting and onboarding usually completes within 30-45 days. Meaningful acquisition volume from a properly vetted partner base typically builds over 60-90 days as partners produce and publish reviewed content.
We work directly with your regulatory and legal reviewers to build and maintain the claims guide and content review process, and with your marketing team on partner strategy and commission structure. Weekly working sessions during buildout cover vetting and workflow progress. If you have an in-house affiliate manager, we become the compliance-integrated program design and partner vetting layer.
Most affiliate agencies optimize for partner volume and conversion rate and treat regulatory compliance as the client's separate problem. We build the claims guide, partner vetting criteria, and content review workflow as core program infrastructure, working directly with your regulatory and legal team from day one. We operate as an embedded team accountable to compliant, sustainable acquisition, not just click and conversion volume.
We track acquisition volume and cost per acquisition by partner, same as any affiliate program, alongside compliance metrics that most programs never measure – disclosure adherence rate and claims review pass rate across live partner content. Both matter, since acquisition volume that requires unwinding a compliance problem later isn't a real return.
Consumer-facing OTC, DTC diagnostic, wellness, and telehealth brands within biotech and pharma where affiliate marketing is a genuinely viable channel are the best fit. This service is not appropriate for prescription products subject to anti-kickback and physician marketing restrictions that prohibit consumer affiliate structures entirely. The first step is scoping which of your products and claims are actually eligible.
Tuesday, June 16, 2026
Frank Growth – Episode 224 – The Bootstrapper’s Revenge with Alex Roy
Tuesday, July 21, 2026
Frank Growth – Episode 229 – Longevity Medicine’s Dirty Secret with Jim Donnelly
Tuesday, September 1, 2026
Frank Growth – Episode 235 – The Marketing Engineer with Nick Lafferty
Tuesday, August 25, 2026
Frank Growth – Episode 234 – Nobody Has The Playbook Yet with Dave Steer
Ready to unlock your growth?
Book Free Call